IV Dressing Market, By Product Type (Transparent, Translucent), By Application (Reusable, Disposable), By End User (Hospitals, Clinics, Others (Ambulatory Surgical Center etc.)), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Sep 2023

Code : CMI3182

Pages :153

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global IV Dressings Market– Drivers

Rising Incidence of Blood Infections: Increasing incidences of infections such as central line-associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and other infections are expected to boost growth of the I.V. dressing market over the forecast period. For instance, according to a research study published by the National Center for Biotechnology Information in March 2022, Centralline-associated bloodstream infections (CLABSIs) continue to be one of the most common preventable healthcare-associated infections in intensive care units (ICUs) in the U.S. in 2020, with a rate of 0.87 per 1,000 centralline days.
Increasing Number of Surgeries: An increasing number of surgical procedures is anticipated to fuel the global IV dressings market’s growth over the forecast period. For instance, according to an article published by The Journal of the American Medical Association (JAMA) in December 2021, from January 1, 2019 to January 30, 2021, a total of 1,3108,567 surgical procedures were identified based on 3,498 Current Procedural Terminology (CPT) codes. These included 5973573 procedures in 2020 (3,156,240 procedures on women [52.8]). Moreover, 482,637 interventions in children [8.1%] and 1,806,074 procedures in patients aged 65 years [30.2%]).

Global IV Dressings Market: Restraint

Complications Associated with I.V. Dressing :
Complications associated with I.V. dressing are expected to hinder growth of the global IV dressing market. These complications include nausea, swelling, discomfort, and others. The most frequently reported peripheral intravenous catheter (PIVC)-related complications include phlebitis, infiltration, obstruction, extravasation, accidental removal, and tube clogging.
Moreover, bacterial contamination of the IV dressing is also expected to limit growth of the market. Phlebitis is one of the most common complications of peripheral IV therapy, which puts the patient at an increased risk of erythema, pain, swelling, localized infection, and catheter-related bloodstream infections. Some of these complications include nasopharyngeal discomfort, pharyngeal or esophageal perforation, intraperitoneal bleeding, peristomal leaks, and gastrocolic fistula formation.